Table 1.
Study | Population | Year | Patients (n) | ECG acquisition | Sampling rate | Analytic program | Percentiles |
---|---|---|---|---|---|---|---|
Rijnbeek et al. | 0 to 16 y; Dutch | 2001 | Male (944); Female (968) | Cardio Control (Delft, Netherlands) | 1200 Hz | MEANSa | 2nd, 50th and 98th |
Wu et al. | 18 to ≥ 60 y; Chinesese | 2003 | Male (3614); Female (1746) | Cardio Control (Delft, Netherlands) | 1200 Hz | MEANSa | 2nd, 50th and 98th |
Mason et al. | 0 to 99 years; Northern America (70%), Europe (21%), Africa (3%), Latin America (3%), and Asia (2%) and Oceania (2%). | 2007 | Male (14,297); Female (12,201) | MTX-2 (CCSSI); MAC 1200 (GE Medical Systems) | 500 Hz | CCSSI | 1st, 2nd, 50th, 98th, 99th |
Rijnbeek et al. | 16 to 89 y; Dutch | 2014 | Male (7326); Female (6028) | ACTA (ESAOTE, Florence, Italy); Cardio Perfect equipment (Welch Allyn Cardio Control, USA); Megacart (Siemens, Erlangen, Germany) | 500 Hz | MEANSa | 2nd, 50th and 98th |
aModular ECG Analysis System (MEANS)